Nuvectis Pharma Inc. (NASDAQ: NVCT) Stock Information | RedChip

Nuvectis Pharma Inc. (NASDAQ: NVCT) Listen to this Section


$6.21
-0.0900 ( -1.43% ) 89.7K

Nuvectis Pharma Inc is a biopharmaceutical company. The company is engaged in the development of innovative precision medicines for the treatment of serious conditions of unmet medical needs in oncology. It operates with one segment, focused on the development of novel targeted small molecule therapeutics for the treatment of cancer in genetically defined patient populations. Its pipeline products include NXP800, NXP900.

Market Data


Open


$6.21

Previous close


$6.30

Volume


89.7K

Market cap


$117.14M

Day range


$6.11 - $6.61

52 week range


$5.85 - $15.50

Insider Ownership Transactions

Total Amount Purchased: -339,447.00 | $ -2,107,965.87

Date Type Amount Purchased Purchaser
2024-06-13 Sale -30000.00 Oliviero James F III
2024-06-13 Sale -30000.00 Hoberman Kenneth
2024-06-13 Sale -30000.00 Kaplan Matthew L.
2024-05-15 Buy 1940.00 BENTSUR RON
2024-05-13 Buy 500.00 Poradosu Enrique
2024-05-13 Buy 1113.00 Shemesh Shay
2024-05-13 Buy 2000.00 BENTSUR RON
2024-03-19 Buy 5000.00 BENTSUR RON
2024-01-05 Sale -130000.00 Poradosu Enrique
2024-01-05 Sale -130000.00 Shemesh Shay

SEC Fillings


Form Type Description Pages Date
8-k 8K-related 15 Aug 06, 2024
10-q Quarterly Reports 48 Aug 06, 2024
4 Insider transactions 1 Jun 13, 2024
4 Insider transactions 1 Jun 13, 2024
8-k 8K-related 13 Jun 13, 2024
4 Insider transactions 1 Jun 13, 2024
4 Insider transactions 1 May 15, 2024
4 Insider transactions 1 May 13, 2024
4 Insider transactions 1 May 13, 2024
4 Insider transactions 1 May 13, 2024

Latest News


Terms and Agreement

Please agree to the terms to continue using the chat feature.